KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Long-Term Investments (2016 - 2026)

Bio-Rad Laboratories has reported Long-Term Investments over the past 15 years, most recently at $5.3 billion for Q1 2026.

  • Quarterly Long-Term Investments rose 6.36% to $5.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.3 billion through Mar 2026, up 6.36% year-over-year, with the annual reading at $6.1 billion for FY2025, 26.13% up from the prior year.
  • Long-Term Investments was $5.3 billion for Q1 2026 at Bio-Rad Laboratories, down from $6.1 billion in the prior quarter.
  • Over five years, Long-Term Investments peaked at $9.7 billion in Q1 2022 and troughed at $4.8 billion in Q4 2024.
  • The 5-year median for Long-Term Investments is $7.2 billion (2023), against an average of $6.8 billion.
  • Year-over-year, Long-Term Investments plummeted 54.04% in 2022 and then increased 26.13% in 2025.
  • A 5-year view of Long-Term Investments shows it stood at $8.8 billion in 2022, then decreased by 12.83% to $7.7 billion in 2023, then tumbled by 37.14% to $4.8 billion in 2024, then increased by 26.13% to $6.1 billion in 2025, then dropped by 12.97% to $5.3 billion in 2026.
  • Per Business Quant, the three most recent readings for BIO's Long-Term Investments are $5.3 billion (Q1 2026), $6.1 billion (Q4 2025), and $5.1 billion (Q3 2025).